4
MARKET OVERVIEW
Highlights the market structure, growth drivers, restraints, and near-term inflection points influencing performance.
4.2.1.1
RISING CHRONIC DISEASE PREVALENCE REQUIRING ADVANCED DIAGNOSTIC AND TREATMENT TOOLS
4.2.1.2
ADMINISTRATIVE BURDEN CRISIS DRIVING URGENT DEMAND FOR AI AUTOMATION SOLUTIONS IN US
4.2.1.3
STRONG FINANCIAL INVESTMENT FROM MAJOR TECH FIRMS AND VENTURE CAPITAL
4.2.1.4
ADVANCED DIGITAL INFRASTRUCTURE AND WIDESPREAD ELECTRONIC HEALTH RECORDS ADOPTION ACROSS US
4.2.2.1
HIGH IMPLEMENTATION COSTS CREATING BARRIERS FOR SMALLER PROVIDERS
4.2.2.2
DATA PRIVACY BREACHES AND CYBERSECURITY VULNERABILITIES
4.2.2.3
REGULATORY UNCERTAINTY AND FRAGMENTED STATE FEDERAL LEGISLATION SLOWING AI DEPLOYMENT
4.2.3.1
ACCELERATED DRUG DISCOVERY AND REDUCED PHARMACEUTICAL DEVELOPMENT TIMELINES
4.2.3.2
PRECISION MEDICINE GROWTH ENABLING PERSONALIZED PATIENT TREATMENT AND BETTER OUTCOMES
4.2.3.3
FRAUD DETECTION CAPABILITIES PROTECTING REVENUE AND REDUCING HEALTHCARE FINANCIAL LOSSES
4.2.4.1
ALGORITHMIC BIAS ISSUES AND HEALTH EQUITY GAPS ACROSS PATIENT POPULATIONS
4.2.4.2
LACK OF AI MODEL TRANSPARENCY CREATING TRUST ISSUES AMONG HEALTHCARE PROVIDERS
4.3
UNMET NEEDS & WHITE SPACES
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Outlines emerging trends, technology impact, and regulatory signals affecting growth trajectory and stakeholder decisions.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC INDICATORS
5.2.2
GDP TRENDS & FORECAST
5.2.3
TRENDS IN HEALTHCARE IT INDUSTRY
5.5.1
INDICATIVE PRICE FOR ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE SOLUTIONS, BY KEY PLAYER (2024)
5.6
KEY CONFERENCES & EVENTS, 2026–2027
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.8
INVESTMENT & FUNDING SCENARIO
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
7.1
REGULATIONS & COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
US ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY OFFERING (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
9.3
NICHE/POINT SOLUTIONS
10
US ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY FUNCTION (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
10.2
DIAGNOSIS & EARLY DETECTION
10.2.2.1.2
CLINICAL CHEMISTRY
10.2.2.1.3
MOLECULAR DIAGNOSTICS
10.2.2.2.1
IMAGE ANALYSIS & INTERPRETATION
10.2.2.2.2
BIOMARKER DISCOVERY & ANALYSIS
10.2.2.2.3
OTHER IVD APPLICATIONS
10.2.3
DIAGNOSTIC IMAGING
10.2.3.1.1
DISEASE INTERPRETATION & REPORT ANALYSIS
10.2.3.1.2
IMAGE CAPTIONING & ANNOTATION
10.2.3.1.3
IMAGE RECONSTRUCTION
10.2.3.1.4
OTHER DIAGNOSTIC IMAGING APPLICATIONS
10.2.3.2.1
MAGNETIC RESONANCE IMAGING (MRI)
10.2.3.2.2
COMPUTED TOMOGRAPHY (CT)
10.2.3.2.5
NUCLEAR IMAGING (PET & SPECT)
10.2.3.2.6
OTHER DIAGNOSTIC IMAGING MODALITIES (OPTICAL IMAGING, ETC.)
10.2.4
RISK ASSESSMENT & PATIENT STRATIFICATION
10.2.5
DRUG ALLERGY ALERTING
10.2.6
OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS
10.3
TREATMENT PLANNING & PERSONALIZATION
10.3.1
PERSONALIZED TREATMENT PLANNING
10.3.1.1
PRECISION MEDICINE & GENOMIC ANALYSIS
10.3.1.2
PREDICTIVE MODELS FOR TREATMENT RESPONSE
10.3.1.3
TREATMENT RECOMMENDATION SYSTEMS
10.3.2
PHARMACOLOGICAL THERAPY
10.3.2.1
DRUG RESPONSE PREDICTION
10.3.2.2
DOSING & ADMINISTRATION
10.3.2.3
OTHER PHARMACOLOGICAL THERAPY FUNCTIONS
10.3.3.1
PREOPERATIVE IMAGING & 3D MODELING
10.3.3.2
INTRAOPERATIVE GUIDANCE & ROBOTICS
10.3.3.3
POSTOPERATIVE ANALYSIS & RECOVERY
10.3.4.1
MOTION SYNCHRONIZATION & AUTO CONTOURING
10.3.4.2
REAL-TIME ADAPTIVE TREATMENT DELIVERY
10.3.4.3
RESPONSE ASSESSMENT & QUALITY ASSURANCE
10.3.4.4
OTHER RADIATION THERAPY FUNCTIONS
10.3.5
BEHAVIORAL & PSYCHOTHERAPY THERAPY
10.3.5.1
VIRTUAL COUNSELING & CHATBOTS
10.3.5.2
PROGRESS MONITORING & FEEDBACK
10.3.5.3
FOLLOW-UP & LONG-TERM SUPPORT
10.3.6.1
REAL-TIME PATIENT DATA MONITORING (IMAGING SCANS, BLOOD BIOMARKERS, VITALS)
10.3.6.2
RESPONSE & SIDE-EFFECT PREDICTION
10.3.6.3
RELAPSE PREDICTION & LONG-TERM MANAGEMENT
10.3.7
OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS
10.4
PATIENT ENGAGEMENT & REMOTE MONITORING
10.4.1
SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE
10.4.2
TELEHEALTH & REMOTE PATIENT MONITORING
10.4.3
HEALTHCARE ASSISTANCE ROBOTS
10.4.4
MEDICATION REMINDERS
10.4.5
PATIENT EDUCATION & EMPOWERMENT
10.4.6
OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS
10.5
POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE
10.5.1
RECURRENCE MONITORING
10.5.2
LONG-TERM OUTCOME PREDICTION
10.5.3
MENTAL HEALTH & SUPPORT SYSTEMS
10.6.2
MEDICATION MANAGEMENT
10.6.3
PHARMACY AUDIT & ANALYSIS
10.6.4
OTHER PHARMACY MANAGEMENT FUNCTIONS
10.7
DATA MANAGEMENT & ANALYTICS
10.8.1
PATIENT REGISTRATION & SCHEDULING
10.8.2
PATIENT ELIGIBILITY & AUTHORIZATION
10.8.3
BILLING & CLAIMS MANAGEMENT
10.8.4
WORKFORCE MANAGEMENT
10.8.5
SUPPLY CHAIN & INVENTORY MANAGEMENT
10.8.6
COMPLIANCE & DOCUMENTATION
10.8.7
HEALTHCARE WORKFLOW MANAGEMENT
10.8.9
CUSTOMER RELATIONSHIP MANAGEMENT
10.8.10
FRAUD DETECTION & RISK MANAGEMENT
10.8.12
OTHER ADMINISTRATIVE FUNCTIONS
11
US ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY APPLICATION (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
11.2
CLINICAL APPLICATIONS
11.3
NON-CLINICAL APPLICATIONS
12
US ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
13
US ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TOOL (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
13.2.1.1
CONVOLUTIONAL NEURAL NETWORKS (CNN)
13.2.1.2
RECURRENT NEURAL NETWORKS (RNN)
13.2.1.3
GENERATIVE ADVERSARIAL NETWORKS (GAN)
13.2.1.4
GRAPH NEURAL NETWORKS (GNN)
13.2.1.5
OTHER DEEP LEARNING TOOLS
13.2.2
SUPERVISED LEARNING
13.2.3
REINFORCEMENT LEARNING
13.2.4
UNSUPERVISED LEARNING
13.2.5
OTHER MACHINE LEARNING TOOLS
13.3
NATURAL LANGUAGE PROCESSING
13.3.1
SENTIMENT ANALYSIS
13.3.2
PATTERN & IMAGE RECOGNITION
13.3.4
CLASSIFICATION & CATEGORIZATION
13.3.6
SPEECH RECOGNITION
13.4
CONTEXT-AWARE COMPUTING
14
US ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY END USER (USD MILLION) (MARKET SIZE & FORECAST TO 2030)
14.2
HEALTHCARE PROVIDERS
14.2.1
HOSPITALS & CLINICS
14.2.2
AMBULATORY CARE CENTERS
14.2.3
HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES
14.2.4
DIAGNOSTIC & IMAGING CENTERS
14.2.6
OTHER HEALTHCARE PROVIDERS
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
15.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN
15.3
REVENUE ANALYSIS, 2020–2024
15.4
MARKET SHARE ANALYSIS,
15.5
BRAND/SOFTWARE COMPARISON
15.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
15.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
15.6.5.1
COMPANY FOOTPRINT
15.6.5.2
OFFERING FOOTPRINT
15.6.5.3
FUNCTION FOOTPRINT
15.6.5.4
APPLICATION FOOTPRINT
15.6.5.5
DEPLOYMENT MODE FOOTPRINT
15.6.5.7
END-USER FOOTPRINT
15.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
15.7.1
PROGRESSIVE COMPANIES
15.7.3
RESPONSIVE COMPANIES
15.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
15.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
15.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
15.8
COMPANY VALUATION & FINANCIAL METRICS
15.9
COMPETITIVE SCENARIO
15.9.1
PRODUCT LAUNCHES & UPGRADES
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, SERVICES, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN THE ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET LANDSCAPE
16.1.1
KONINKLIJKE PHILIPS N.V.
15.1.1.1
BUSINESS OVERVIEW
15.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
15.1.1.3
RECENT DEVELOPMENTS
15.1.1.3.2
STRATEGIC CHOICES
15.1.1.3.3
WEAKNESSES & COMPETITIVE THREATS
16.1.2
MICROSOFT CORPORATION
16.1.3
SIEMENS HEALTHINEERS AG
16.1.4
NVIDIA CORPORATION
16.1.5
EPIC SYSTEMS CORPORATION
16.1.12
RIVERIAN TECHNOLOGIES
16.1.13
JOHNSON & JOHNSON
16.1.14
AMAZON WEB SERVICES
16.1.16
TERARECON (CONCERTAI)
16.1.19
SOLVENTUM CORPORATION
17.1.1.1
KEY DATA FROM SECONDARY SOURCES
17.1.2.1
KEY DATA FROM PRIMARY SOURCES
17.1.2.2
KEY PRIMARY PARTICIPANTS
17.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
17.1.2.4
KEY INDUSTRY INSIGHTS
17.2
MARKET SIZE ESTIMATION
17.2.1
BOTTOM-UP APPROACH
17.2.3
BASE NUMBER CALCULATION
17.3
MARKET FORECAST APPROACH
17.6
RESEARCH ASSUMPTIONS
17.7
RESEARCH LIMITATIONS & RISK ASSESSMENT
18.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3
CUSTOMIZATION OPTIONS
Growth opportunities and latent adjacency in US Artificial Intelligence (AI) in Healthcare Market